Hydralazine Hydrochloride Tablet
Product Images NDC 68788-8087

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 68788-8087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydralazine HCl Tab Usp 100mg (100mg100sannora)

Hydralazine HCI is a generic medication used as an alternative to Apresoline. Each tablet contains 100mg of hydralazine hydrochloride, USP. This medication is manufactured by Camber Pharmaceuticals, Inc. located in Piscataway, NJ. The tablets are orange and round with "i/31" imprinted on them. The recommended dose is to be taken multiple times per day as directed in the English or Spanish instructions. Federal law prohibits the transfer of this medication to anyone other than the patient for whom it was prescribed. Details on package size, expiration date, lot number, batch number, and product number are listed on the packaging.*

FDA Label Image

Label12 (Label12)

FDA Label Image

Hydralazinecamber1 (Hydralazinecamber1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.